Douglas A. Treco
CIK: 0001688192
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jun 5, 2026CRSP
CRISPR Therapeutics AG
Award(A)DirectStock Option (Right to Buy)
13K shares- - Aug 6, 2025CRSP
CRISPR Therapeutics AG
Purchase(P)Direct20K shares at avg. $57.03$1.1M - Jul 1, 2025INZY
Inozyme Pharma, Inc.
Disposition(D)DirectRestricted Stock Units
150K shares- - Jul 1, 2025INZY
Inozyme Pharma, Inc.
Tender Offer(U)Direct43.9K shares at avg. $4.00$175K - Jul 1, 2025INZY
Inozyme Pharma, Inc.
Disposition(D)DirectStock Option (Right to Buy)
87K shares- - Jul 1, 2025INZY
Inozyme Pharma, Inc.
Disposition(D)DirectStock Option (Right to Buy)
400K shares- - Jun 25, 2025INZY
Inozyme Pharma, Inc.
Award(A)Direct2.8K shares at avg. $0.74$2K - Jun 5, 2025CRSP
CRISPR Therapeutics AG
Award(A)DirectStock Option (Right to Buy)
13K shares- - Apr 2, 2025INZY
Inozyme Pharma, Inc.
Sale(S)Direct8.8K shares at avg. $0.89$8K - Apr 1, 2025INZY
Inozyme Pharma, Inc.
Exercise(M)Direct25K shares- - Mar 11, 2025INZY
Inozyme Pharma, Inc.
Award(A)DirectRestricted Stock Units
100K shares- - Mar 11, 2025INZY
Inozyme Pharma, Inc.
Award(A)DirectStock Option (right to buy)
400K shares- - Sep 30, 2024INZY
Inozyme Pharma, Inc.
Award(A)Direct1.7K shares at avg. $4.45$8K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 5, 2026 |  CRSP CRISPR Therapeutics AG | Award(A) Stock Option (Right to Buy) | 13,000 | - | - | Direct |
| Aug 6, 2025 | CRSP CRISPR Therapeutics AG | Purchase(P) | 20,000 | $57.03 | $1,140,600 | Direct |
| Jul 1, 2025 |  INZY Inozyme Pharma, Inc. | Disposition(D) Restricted Stock Units | 150,000 | - | - | Direct |
| Jul 1, 2025 | INZY Inozyme Pharma, Inc. | Tender Offer(U) | 43,861 | $4.00 | $175,444 | Direct |
| Jul 1, 2025 | INZY Inozyme Pharma, Inc. | Disposition(D) Stock Option (Right to Buy) | 86,979 | - | - | Direct |
| Jul 1, 2025 | INZY Inozyme Pharma, Inc. | Disposition(D) Stock Option (Right to Buy) | 400,000 | - | - | Direct |
| Jun 25, 2025 | INZY Inozyme Pharma, Inc. | Award(A) | 2,815 | $0.74 | $2,083 | Direct |
| Jun 5, 2025 | CRSP CRISPR Therapeutics AG | Award(A) Stock Option (Right to Buy) | 13,000 | - | - | Direct |
| Apr 2, 2025 | INZY Inozyme Pharma, Inc. | Sale(S) | 8,819 | $0.89 | $7,849 | Direct |
| Apr 1, 2025 | INZY Inozyme Pharma, Inc. | Exercise(M) | 25,000 | - | - | Direct |
| Mar 11, 2025 | INZY Inozyme Pharma, Inc. | Award(A) Restricted Stock Units | 100,000 | - | - | Direct |
| Mar 11, 2025 | INZY Inozyme Pharma, Inc. | Award(A) Stock Option (right to buy) | 400,000 | - | - | Direct |
| Sep 30, 2024 | INZY Inozyme Pharma, Inc. | Award(A) | 1,710 | $4.45 | $7,610 | Direct |
1-13 of 13 transactions
About Treco Douglas A
Treco Douglas A (SEC CIK 0001688192) files insider reports with the SEC as Director of CRISPR Therapeutics AG (CRSP) and CEO of Inozyme Pharma, Inc. (INZY).
Signal8 holds 8 ownership filings by Treco Douglas A, all Form 4s, filed between Oct 3, 2024 and Jun 9, 2026. Those filings report 13 transactions, from Sep 30, 2024 to Jun 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Treco Douglas A's filings is in BOSTON, MA.
Recent filings by Treco Douglas A
- Jun 5, 2026: Grant or award of CRSP derivative securities (Form 4, code A).
- Aug 6, 2025: Open-market purchase of CRSP shares (Form 4, code P).
- Jul 1, 2025: Disposition to issuer transaction of INZY derivative securities (Form 4, code D).
- Jul 1, 2025: Tender of shares transaction of INZY shares (Form 4, code U).
- Jul 1, 2025: Disposition to issuer transactions of INZY derivative securities (2 lines, Form 4, code D).
Other insiders filing for CRISPR Therapeutics AG (CRSP)
- Sakhamuri Sivakesava, Chief Technical Officer
- Silver Andrew Jacob, Chief Financial Officer
- KASINGER JAMES R., General Counsel and Secretary
- Kulkarni Samarth, Chief Executive Officer
- Patel Naimish, Chief Medical Officer
- George Simeon, Director